Literature DB >> 1772427

A spectrophotometric modification of a sensitive densitometric Safranin O assay for glycosaminoglycans.

D A Carrino1, J L Arias, A I Caplan.   

Abstract

Recently, an assay for quantification of glycosaminoglycans has been reported based on precipitation with Safranin O (Lammi, M. and Tammi, M. (1988) Anal. Biochem. 168, 352-357). In this procedure, the precipitate which forms when the glycosaminoglycan or proteoglycan is mixed with the Safranin O is collected with a dot-blot apparatus onto a membrane filter. The intensity of the color in the dots is measured densitometrically and is proportional to the amount of glycosaminoglycan or proteoglycan in the sample. This report describes a modification of the densitometric Safranin O assay which allows its use as a spectrophotometric assay. For this, the precipitates are solubilized in cetylpyridinium chloride and the absorbance determined for the resulting solutions. As with the densitometric method, guanidinium chloride diminishes the color intensity. However, the color is stable, even after solubilization, for at least one week. The precipitates collected from as much as 10 micrograms of material can be solubilized in as little as 100 microliters of cetylpyridinium chloride, so that increased sensitivity may be obtained if the solubilized precipitate is measured in a microcuvet. Thus, solubilization with cetylpyridinium chloride allows use of the Safranin O assay for glycosaminoglycans and proteoglycans even when a densitometer is unavailable.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1772427

Source DB:  PubMed          Journal:  Biochem Int        ISSN: 0158-5231


  25 in total

1.  Age-related differences in human skin proteoglycans.

Authors:  David A Carrino; Anthony Calabro; Aniq B Darr; Maria T Dours-Zimmermann; John D Sandy; Dieter R Zimmermann; J Michael Sorrell; Vincent C Hascall; Arnold I Caplan
Journal:  Glycobiology       Date:  2010-10-14       Impact factor: 4.313

2.  High-throughput aggregate culture system to assess the chondrogenic potential of mesenchymal stem cells.

Authors:  Kitsie J Penick; Luis A Solchaga; Jean F Welter
Journal:  Biotechniques       Date:  2005-11       Impact factor: 1.993

3.  Tissue engineering of a composite trachea construct using autologous rabbit chondrocytes.

Authors:  James E Dennis; Kristina G Bernardi; Thomas J Kean; Nelson E Liou; Tanya K Meyer
Journal:  J Tissue Eng Regen Med       Date:  2017-11-10       Impact factor: 3.963

4.  Simplification of aggregate culture of human mesenchymal stem cells as a chondrogenic screening assay.

Authors:  Jean F Welter; Luis A Solchaga; Kitsie J Penick
Journal:  Biotechniques       Date:  2007-06       Impact factor: 1.993

5.  [Cartilage grafts generated by tissue engineering. Histomorphological, immunochemical and biomechanical properties].

Authors:  A Naumann
Journal:  HNO       Date:  2008-02       Impact factor: 1.284

6.  MSC frequency correlates with blood vessel density in equine adipose tissue.

Authors:  Lindolfo da Silva Meirelles; Theodore T Sand; Robert J Harman; Donald P Lennon; Arnold I Caplan
Journal:  Tissue Eng Part A       Date:  2009-02       Impact factor: 3.845

7.  Dynamics of Intrinsic Glucose Uptake Kinetics in Human Mesenchymal Stem Cells During Chondrogenesis.

Authors:  Yi Zhong; Mostafa Motavalli; Kuo-Chen Wang; Arnold I Caplan; Jean F Welter; Harihara Baskaran
Journal:  Ann Biomed Eng       Date:  2018-06-14       Impact factor: 3.934

8.  Massive aggrecan and versican accumulation in thoracic aortic aneurysm and dissection.

Authors:  Frank S Cikach; Christopher D Koch; Timothy J Mead; Josephine Galatioto; Belinda B Willard; Kelly B Emerton; Matthew J Eagleton; Eugene H Blackstone; Francesco Ramirez; Eric E Roselli; Suneel S Apte
Journal:  JCI Insight       Date:  2018-03-08

9.  Low oxygen tension during incubation periods of chondrocyte expansion is sufficient to enhance postexpansion chondrogenesis.

Authors:  James H Henderson; Nell M Ginley; Arnold I Caplan; Christopher Niyibizi; James E Dennis
Journal:  Tissue Eng Part A       Date:  2010-05       Impact factor: 3.845

10.  Scaffold-free tissue-engineered cartilage implants for laryngotracheal reconstruction.

Authors:  David A Gilpin; Mark S Weidenbecher; James E Dennis
Journal:  Laryngoscope       Date:  2010-03       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.